Your browser doesn't support javascript.
loading
Innovative health risk assessment of heavy metals in Chinese herbal medicines based on extensive data.
Zuo, Tian-Tian; Jin, Hong-Yu; Zhang, Lei; Liu, Yong-Li; Nie, Jing; Chen, Bi-Lian; Fang, Cui-Fen; Xue, Jian; Bi, Xue-Yan; Zhou, Li; Shen, Ming-Rui; Shi, Shang-Mei; Ma, Shuang-Cheng.
Afiliação
  • Zuo TT; National Institutes for Food and Drug Control, Beijing, 100050, China; Xi'an Jiaotong University, Xi'an, 710049, China. Electronic address: zuotiantian2011@163.com.
  • Jin HY; National Institutes for Food and Drug Control, Beijing, 100050, China. Electronic address: jhyu@nifdc.org.cn.
  • Zhang L; China National Center for Food Safety Risk Assessment, Beijing, 100082, China. Electronic address: zhanglei@cfsa.net.cn.
  • Liu YL; Hebei Institute for Drug Control, Shijiazhuang, 050011, China. Electronic address: liuyongli2008@126.com.
  • Nie J; Hubei Institute for Drug Control, Wuhan, 430075, China. Electronic address: niejingwh@sina.com.
  • Chen BL; Zhejiang Institute for Food and Drug Control, Hangzhou, 310052, China. Electronic address: zsyonly@hotmail.com.
  • Fang CF; Zhejiang Institute for Food and Drug Control, Hangzhou, 310052, China. Electronic address: fcf0507@126.com.
  • Xue J; Institute of Medicinal Plant Development, Beijing, 100193, China. Electronic address: jxue@implad.ac.cn.
  • Bi XY; Heilongjiang Institute for Drug Control, Harbin, 150088, China. Electronic address: 65554629@qq.com.
  • Zhou L; National Resource Center for Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, 100700, China. Electronic address: zhouli3131@163.com.
  • Shen MR; Chinese Pharmacopeia Commission, Beijing, 100061, China. Electronic address: shenmingrui@chp.org.cn.
  • Shi SM; Chinese Pharmacopeia Commission, Beijing, 100061, China. Electronic address: ssm@chp.org.cn.
  • Ma SC; Xi'an Jiaotong University, Xi'an, 710049, China. Electronic address: masc@nifdc.org.cn.
Pharmacol Res ; 159: 104987, 2020 09.
Article em En | MEDLINE | ID: mdl-32512044
ABSTRACT
In the present study, the concentrations of lead (Pb), cadmium (Cd), arsenic (As), mercury (Hg), and copper (Cu) in 2245 batches of Chinese herbal medicines (CHMs) were measured using inductively coupled plasma-mass spectroscopy (ICP-MS). We developed a risk assessment strategy that assessed the heavy metal-associated health risk of CHMs based on our large dataset. Using a combination of the mean and 95th percentile (P95) values of the chronic daily intake (CDI), hazard quotient (HQ), hazard index (HI), and lifetime cancer risk (CR), the health risks of the average exposure population and the high exposure population were estimated, respectively. To obtain a precise and realistic risk assessment, the exposure frequency and exposure duration were determined using questionnaire data from 20,917 randomly selected volunteers. Additionally, given the specific ingestion characteristics of CHMs, the safety factor and the transfer rates of heavy metals were highlighted as well. The concentrations of Pb, Cd, As, Hg, and Cu in 2245 batches of CHMs were 1.566, 0.299, 0.391, 0.074, and 8.386 mg/kg, respectively. The mean HI values indicated that consumption of most CHMs would not pose an unacceptable health risk to the average exposure population, except for argy wormwood leaf (1.326), morinda root (2.095), plantain herb (1.540), chrysanthemum flower (1.146), and Indian madder root (2.826). In addition, CR assessment for Pb and As revealed that, for the average exposure population, the risk of developing cancers was lower than the acceptable levels (1 × 10-4) in the clinic. However, the P95 of the HI and CR values indicated that more attention should be paid to the systemic effects of CHMs in terms of both non-carcinogenic and carcinogenic health risks for the high exposure population. Furthermore, in order to serve population health better, national and international guidelines have now been established. The risk assessment strategy developed in this study is the first of its kind, and contributed to the risk assessment, guidelines, and safety standards for heavy metals in CHMs.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Medicinas Tradicionais: Medicinas_tradicionales_de_asia / Medicina_china Assunto principal: Medicamentos de Ervas Chinesas / Contaminação de Medicamentos / Metais Pesados Tipo de estudo: Etiology_studies / Guideline / Qualitative_research / Risk_factors_studies Idioma: En Revista: Pharmacol Res Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Medicinas Tradicionais: Medicinas_tradicionales_de_asia / Medicina_china Assunto principal: Medicamentos de Ervas Chinesas / Contaminação de Medicamentos / Metais Pesados Tipo de estudo: Etiology_studies / Guideline / Qualitative_research / Risk_factors_studies Idioma: En Revista: Pharmacol Res Ano de publicação: 2020 Tipo de documento: Article